Specialty Injectable Generics Market Insights Video
According to Cognitive Market Research, the global Specialty Injectable Generic market size will be USD 77514.6 million in 2024. It will expand at a compound annual growth rate (CAGR) of 16.20% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 31005.84 million in 2024 and will grow at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 23254.38 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 17828.36 million in 2024 and will grow at a compound annual growth rate (CAGR) of 18.2% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 3875.73 million in 2024 and will grow at a compound annual growth rate (CAGR) of 15.6% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 1550.29 million in 2024 and will grow at a compound annual growth rate (CAGR) of 15.9% from 2024 to 2031.
The biologics speciality injectable generics category is the fastest growing segment of the Specialty Injectable Generic industry
